In Oregon and Colorado, you can book an appointment for psilocybin therapy, where a licensed therapist takes you on a guided trip using the drug that makes “magic” mushrooms hallucinogenic.

Under federal law, psilocybin is illegal. But within the past few years, both states greenlit the drug for supervised medical use, and New Mexico may soon follow. It’s being used to treat certain conditions, including drug-resistant depression and PTSD. With a lot more people taking the drug under state supervision, what are we learning about its safety and efficacy? Who is taking it, and can clinics make money?

Host Flora Lichtman checks in on the state of these programs with Colorado Public Radio journalist Alejandro Galva. Then, she sits down with geriatric and palliative care specialist Stacy Fischer for a research update on the therapeutic use of the drug, and the nation’s largest clinical trial for psilocybin use for advanced cancer patients facing mental health challenges.

Guests:
Alejandro Galva is the afternoon editor at Colorado Public Radio. He’s also the editor of their series “The Trip,” which covers the psychedelic therapy landscape in the state.
Dr. Stacy Fischer is a geriatric and palliative care specialist at UCHealth University of Colorado Hospital.

Transcripts for each episode are available within 1-3 days at sciencefriday.com.

Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that’s keeping you up at night? Call us: 877-472-4374

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.